1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8 "Hepatology")
fax: 617-632 0880.
1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
Liver Biology and Pathobiology
You have full text access to this OnlineOpen article
A20 protects mice from lethal radical hepatectomy by promoting hepatocyte proliferation via a p21waf1-dependent mechanism†
Article first published online: 16 JUN 2005
DOI: 10.1002/hep.20741
Copyright © 2005 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Longo, C. R., Patel, V. I., Shrikhande, G. V., Scali, S. T., Csizmadia, E., Daniel, S., Sun, D. W., Grey, S. T., Arvelo, M. B. and Ferran, C. (2005), A20 protects mice from lethal radical hepatectomy by promoting hepatocyte proliferation via a p21waf1-dependent mechanism. Hepatology, 42: 156–164. doi: 10.1002/hep.20741
- †
Potential conflict of interest: Nothing to report.
Publication History
- Issue published online: 16 JUN 2005
- Article first published online: 16 JUN 2005
- Manuscript Revised: 31 MAR 2005
- Manuscript Received: 7 JAN 2005
Funded by
- US National Institutes of Health (NIH). Grant Numbers: DK063275, T32 HL07734
- Institut National de la Santé et de la Recherche Médicale (INSERM) France
- Association pour la Recherche sur le Cancer (ARC) France
References
- 1. Acute Liver Failure. N Engl J Med 1993; 329: 1862–1872.
- 2, , . Fulminant hepatic failure. N Engl J Med 1968; 279: 798–801.
- 3, , , , . Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000; 6: 163–169.
- 4. Liver regeneration. J Hepatol 2000; 32: 19–31.
- 5, . Liver regeneration. Science 1997; 276: 60–66.
- 6, , , . The A20 zinc finger protein protects cells from TNF cytotoxicity. J Biol Chem 1992; 267: 12424–12427.
- 7, , , , , . A20 blocks endothelial cell activation through a NF-κB-dependent mechanism. J Biol Chem 1996; 271: 18068–18073.
- 8, , , , . A20 inhibits cytokine-induced apoptosis and nuclear factor κB-dependent gene activation in islets. J Exp Med 1999; 190: 1135–1145.
- 9, , , , , , et al. A20 protects mice from galactosmine/lipopolysaccharide acute toxic lethal hepatitis. HEPATOLOGY 2002; 35: 535–543.Direct Link:
- 10, , , , , , et al. A20 inhibits NF-κB activation in endothelial cells without sensitizing to TNF-mediated apoptosis. Blood 1998; 91: 2249–2258.
- 11, , , , , , et al. A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation. Blood 2004; 104: 2376–2384.
- 12, , , , , , et al. Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science 2000; 289: 2350–2354.
- 13, , . Progressive necrosis after hepatectomy and the pathophysiology of liver failure after massive resection. Surgery 1997; 121: 142–149.
- 14, . Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A 2001; 98: 31–36.
- 15, . IκB: a specific inhibitor of the NF-κB transcription factor. Science 1988; 242: 540–546.
- 16, , . Liver regeneration. 2. Role of growth factors and cytokines during liver regeneration. FASEB J 1995; 9: 1527–1536.
- 17, , , , , , et al. A model to predict survival in patients with end-stage liver disease. HEPATOLOGY 2001; 33: 464–470.Direct Link:
- 18, . Blood coagulation. Biochemistry (Mosc) 2002; 67: 3–12.
- 19, , , , , , et al. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J Virol 1997; 71: 8798–8807.
- 20, , , , , , et al. Targets of the cyclin-dependent kinase Cdk1. Nature 2003; 425: 859–864.
- 21, , , , , , et al. Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology 2000; 119: 446–460.
- 22, , , . Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci USA 1997; 94: 1441–1446.
- 23, , , , . Suppression of TNF-α-induced apoptosis by NF-κB. Science 1996; 274: 787–789.
- 24, . An essential role for NF-κB in preventing TNF-α-induced cell death. Science 1996; 274: 782–784.
- 25, , , , . Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 1999; 284: 321–325.
- 26, , , , , , et al. NF-κB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest 1998; 101: 802–811.
- 27, . NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases. Gastroenterology 2000; 118: 1208–1228.
- 28, , . TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-&kg;rB. Science 1996; 274: 784–787.
- 29, , , , . Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 1995; 376: 167–170.
- 30, , , , , , et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996; 274: 1379–1383.
- 31, , , , , . Interleukin 6 is important for survival after partial hepatectomy in mice. HEPATOLOGY 2003; 38: 674–682.Direct Link:
- 32, , , , . Liver regeneration induced by a designer human IL-6/sIL-6R protein reverses severe hepatocellular injury. FASEB J 2000; 14: 1979–1987.
- 33, , , , , , et al. Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J Clin Invest 2003; 112: 989–998.
- 34, , , , , , et al. In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. Gastroenterology 2003; 125: 202–215.
- 35, , , , , , et al. In vivo hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway. Oncogene 1998; 17: 1039–1044.
- 36, , . Regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1/Sdi1) gene expression in hepatic regeneration. HEPATOLOGY 1997; 25: 557–563.Direct Link:
- 37, , , , , . Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver. Oncogene 1998; 16: 2141–2150.
- 38, , , , , . Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration. Genes Dev 1996; 10: 245–260.
- 39, , , , . p53-independent induction of p21WAF1/CIP1 expression in pericentral hepatocytes following carbon tetrachloride intoxication. Cell Growth Differ 1997; 8: 951–961.
- 40, , , . The Cdk inhibitor p21 is required for necrosis, but it inhibits apoptosis following toxin-induced liver injury. J Biol Chem 2003; 278: 30348–30355.
- 41, , , , , , et al. Regenerating livers of old rats contain high levels of C/EBPalpha that correlate with altered expression of cell cycle associated proteins. Nucleic Acids Res 1998; 26: 3293–3299.
- 42, , , , , , et al. CCAAT enhancer- binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy. J Clin Invest 1998; 102: 996–1007.
- 43, , , , , , et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 2004; 430: 694–699.
- 44, , , , , , et al. Human liver regeneration: hepatic energy economy is less efficient when the organ is diseased. HEPATOLOGY 2001; 34: 557–565.Direct Link:
- 45, , , . Complete reconstitution of mouse liver with xenogeneic hepatocytes. Proc Natl Acad Sci USA 1995; 92: 4942–4946.
- 46, , , , , , et al. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat Gen 1994; 6: 335–341.
- 47, , , , , . Minimum graft volume for successful adult-to-adult living donor liver transplantation for fulminant hepatic failure. Transplantation 1996; 62: 696–698.
- 48, , , , , , et al. Long-term results of pediatric liver transplantation. Ann Surg 1998; 228: 411–420.
- 49, , . Live donor transplantation: Strategies for expanding the adult organ donor pool. Conference report 2001; 1st Annual Winter Symposium: Living donor adult-to-adult transplantation of the kidney and liver.